13-32311475-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136571.2(ZAR1L):c.451G>A(p.Glu151Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000252 in 1,546,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001136571.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZAR1L | NM_001136571.2 | c.451G>A | p.Glu151Lys | missense_variant | 3/6 | ENST00000533490.7 | NP_001130043.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZAR1L | ENST00000533490.7 | c.451G>A | p.Glu151Lys | missense_variant | 3/6 | 5 | NM_001136571.2 | ENSP00000437289 | P1 | |
ZAR1L | ENST00000345108.6 | c.451G>A | p.Glu151Lys | missense_variant | 1/4 | 1 | ENSP00000344616 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 7AN: 146408Hom.: 0 AF XY: 0.0000636 AC XY: 5AN XY: 78620
GnomAD4 exome AF: 0.0000251 AC: 35AN: 1393922Hom.: 0 Cov.: 31 AF XY: 0.0000305 AC XY: 21AN XY: 687784
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.451G>A (p.E151K) alteration is located in exon 1 (coding exon 1) of the ZAR1L gene. This alteration results from a G to A substitution at nucleotide position 451, causing the glutamic acid (E) at amino acid position 151 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at